RU2004112422A - Роувастатин в преддеменционных состояниях - Google Patents

Роувастатин в преддеменционных состояниях Download PDF

Info

Publication number
RU2004112422A
RU2004112422A RU2004112422/14A RU2004112422A RU2004112422A RU 2004112422 A RU2004112422 A RU 2004112422A RU 2004112422/14 A RU2004112422/14 A RU 2004112422/14A RU 2004112422 A RU2004112422 A RU 2004112422A RU 2004112422 A RU2004112422 A RU 2004112422A
Authority
RU
Russia
Prior art keywords
rouvastatin
prededentional
conditions
patient
rosuvastatin
Prior art date
Application number
RU2004112422/14A
Other languages
English (en)
Russian (ru)
Inventor
Ханс БАСУН (SE)
Ханс БАСУН
Тимоти ПАЙЗЕР (US)
Тимоти ПАЙЗЕР
Айхор РАК (US)
Айхор РАК
Original Assignee
Астразенека Аб (Se)
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека Аб (Se), Астразенека Аб filed Critical Астразенека Аб (Se)
Publication of RU2004112422A publication Critical patent/RU2004112422A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
RU2004112422/14A 2001-10-19 2002-10-18 Роувастатин в преддеменционных состояниях RU2004112422A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103509A SE0103509D0 (sv) 2001-10-19 2001-10-19 Rosuvastatin in pre demented states
SE0103509-6 2001-10-19

Publications (1)

Publication Number Publication Date
RU2004112422A true RU2004112422A (ru) 2005-04-10

Family

ID=20285721

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004112422/14A RU2004112422A (ru) 2001-10-19 2002-10-18 Роувастатин в преддеменционных состояниях

Country Status (19)

Country Link
US (1) US20060229321A1 (cg-RX-API-DMAC7.html)
EP (1) EP1446123A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005505605A (cg-RX-API-DMAC7.html)
KR (1) KR20040058201A (cg-RX-API-DMAC7.html)
CN (1) CN1604780A (cg-RX-API-DMAC7.html)
AR (1) AR036891A1 (cg-RX-API-DMAC7.html)
BR (1) BR0213434A (cg-RX-API-DMAC7.html)
CA (1) CA2463597A1 (cg-RX-API-DMAC7.html)
CO (1) CO5580773A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0401798A3 (cg-RX-API-DMAC7.html)
IL (1) IL161380A0 (cg-RX-API-DMAC7.html)
IS (1) IS7218A (cg-RX-API-DMAC7.html)
MX (1) MXPA04003631A (cg-RX-API-DMAC7.html)
NO (1) NO20041840L (cg-RX-API-DMAC7.html)
PL (1) PL369573A1 (cg-RX-API-DMAC7.html)
RU (1) RU2004112422A (cg-RX-API-DMAC7.html)
SE (1) SE0103509D0 (cg-RX-API-DMAC7.html)
WO (1) WO2003032995A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200402844B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2537271A1 (en) 2003-08-28 2005-03-17 Teva Pharmaceutical Industries, Ltd. Process for preparation of rosuvastatin calcium
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
US7777034B2 (en) 2003-11-24 2010-08-17 Teva Pharmaceutical Industries Ltd. Crystalline ammonium salts of rosuvastatin
CN1894221B (zh) 2003-12-02 2012-08-08 特瓦制药工业有限公司 用于表征罗苏伐他汀的参照标准品
US7179916B2 (en) 2004-07-13 2007-02-20 Teva Pharmaceutical Industries Ltd. Process for the preparation of rosuvastatin
CA2680693A1 (en) 2005-02-22 2006-08-31 Teva Pharmaceutical Industries Ltd. Preparation of rosuvastatin
WO2007022488A2 (en) 2005-08-16 2007-02-22 Teva Pharmaceutical Industries Ltd. Crystalline rosuvastatin intermediate
WO2012073256A1 (en) 2010-11-29 2012-06-07 Cadila Healthcare Limited Salts of rosuvastatin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
US7189703B2 (en) * 1998-01-09 2007-03-13 Intracell, Llc Treatment and diagnosis of alzheimer's disease
AR022462A1 (es) * 1999-02-06 2002-09-04 Astrazeneca Uk Ltd Uso de un agente que disminuye el colesterol
US20030100493A1 (en) * 2001-07-19 2003-05-29 Sol Weiss Sublingual use of inhibitors in the biosynthesis of cholesterol

Also Published As

Publication number Publication date
WO2003032995A1 (en) 2003-04-24
PL369573A1 (en) 2005-05-02
CO5580773A2 (es) 2005-11-30
KR20040058201A (ko) 2004-07-03
BR0213434A (pt) 2004-11-09
ZA200402844B (en) 2005-01-24
HUP0401798A3 (en) 2005-06-28
US20060229321A1 (en) 2006-10-12
WO2003032995A8 (en) 2004-06-03
NO20041840L (no) 2004-05-05
AR036891A1 (es) 2004-10-13
EP1446123A1 (en) 2004-08-18
HUP0401798A2 (hu) 2005-01-28
MXPA04003631A (es) 2004-07-30
SE0103509D0 (sv) 2001-10-19
CN1604780A (zh) 2005-04-06
CA2463597A1 (en) 2003-04-24
IS7218A (is) 2004-04-13
JP2005505605A (ja) 2005-02-24
IL161380A0 (en) 2004-09-27

Similar Documents

Publication Publication Date Title
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
DE60128258D1 (de) Indanylderivate zur Behandlung von Atemwegserkrankungen
NO20022014L (no) En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
DK0503440T3 (da) Sumatriptanholdige lægemidler
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
JP2005511619A5 (cg-RX-API-DMAC7.html)
EP1440689A3 (en) Treatment of neurotic disorders
RU2004112422A (ru) Роувастатин в преддеменционных состояниях
JP2005505605A5 (cg-RX-API-DMAC7.html)
RU2002117537A (ru) Способ лечения последствий тканевой гипоксии у пациентов в критическом состоянии
CA2432177A1 (en) Drug for prevention and/or therapy of endometriosis
BR0009080A (pt) Método de tratamento da apnéia do sono
SE9901572D0 (sv) New compounds
FI20011464A0 (fi) Yhdistelmäterapia sydämen vajaatoiminnan hoitoon
NZ542305A (en) Treatment of proliferative diseases with an epothilone derivative and radiation
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
RU2005131943A (ru) Лечебные и/или профилактические средства для хронических болезней кожи
HUP0301873A2 (hu) Gyógyszerkészítmény légzési nehézségek kezelésére
TNSN99158A1 (ar) طريقة لمنع الاصابة بالربو
DE60206391D1 (de) Verwendung von thiazolderivaten zur herstellung eines medikaments zur behandlung von chronischen obstruktiven atemwegserkrankungen
DE60235965D1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20060111